Vir Biotechnology Inc [VIR] stock prices are saw in change for the day to $5.18 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VIR shares have gain 3.60% over the last week, with a monthly amount glided 18.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vir Biotechnology Inc [NASDAQ: VIR] stock has seen the most recent analyst activity on September 03, 2025, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $12. Previously, BofA Securities upgraded its rating to Buy on August 27, 2025, and kept the price target unchanged to $14. On January 29, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $9 on the stock. BofA Securities downgraded its rating to a Neutral and decreased its price target to $14 on September 08, 2023. JP Morgan upgraded its rating to a Overweight and reduced its price target to $34 on March 06, 2023. Goldman upgraded its rating to Buy for this stock on February 21, 2023, and upped its price target to $53. In a note dated January 27, 2023, Morgan Stanley upgraded an Equal-Weight rating on this stock and boosted its target price from $18 to $30.
The stock price of Vir Biotechnology Inc [VIR] has been fluctuating between $4.16 and $14.45 over the past year. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Vir Biotechnology Inc [NASDAQ: VIR] shares were valued at $5.18 at the most recent close of the market. An investor can expect a potential return of 131.66% based on the average VIR price forecast.
Analyzing the VIR fundamentals
The Vir Biotechnology Inc [NASDAQ:VIR] reported sales of 19.00M for trailing twelve months, representing a drop of -60.52%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at -35.62%, Pretax Profit Margin comes in at -33.0%, and Net Profit Margin reading is -33.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.46, Equity is -0.5 and Total Capital is -0.55. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Vir Biotechnology Inc [NASDAQ:VIR]’s Current Ratio is 7.01. Also, the Quick Ratio is 7.01, while the Cash Ratio stands at 2.85. Considering the valuation of this stock, the price to sales ratio is 37.87, the price to book ratio is 0.76.
Transactions by insiders
Recent insider trading involved SATO VICKI L, Director, that happened on Sep 02 ’25 when 22000.0 shares were sold. Director, SATO VICKI L completed a deal on Aug 01 ’25 to sell 22000.0 shares. Meanwhile, EVP and Chief Medical Officer Eisner Mark sold 6796.0 shares on Jul 15 ’25.
